The Fierce 50 - presented by FiercePharma - is about people and organizations who are inside the halls of big pharma or major health systems, pulling levers most of us will never see. Some are outside, building new tools, new companies, new rules.

Amid a slowing economy and stagnant job market, even career experts aren’t sure what advice to give job seekers. 

According to Morgan Williams, Founder and CEO of PeakHR, “The current market has pushed job seekers and recruiters alike into “truly uncharted territory.”

According to Leigh Henderson,  Founder of HRManifesto with 20 years of Human Resources experience, there are many questions employers cannot legally ask during a job interview, but that doesn't mean they don't.

When interviewing, remember that your body language can be just as important and communicative as your resume.

According to Benjamin Granger, Chief Workplace Psychologist at Qualtrics, your posture, expression, and behavior are key to making a good first impression.

With the rise of clinical trial complexity, CROs have become valuable partners. FiercePharma has put together a list of CRO award winners that were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability, and Ethical and Regulatory Adherence.

Bayer’s Kerendia was first approved to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes in 2021.

Pitchbook’s look back at the first 6 months of 2025 and projects on the second half of the year.

This is an interesting look at how some small changes can help you sound confident and help you gain respect.

GE HealthCare’s Vizamyl, which was first approved by the FDA in 2013, has been approved to expanded uses that enable more objective scans and the ability to track the benefits of new therapies.

According to the Federal Bank of St. Louis, businesses are hiring at one of the slowest rates since 2015.

If you are currently searching for a job, experts recommend tapping into your network as much as possible and celebrating the small wins - even if they’re as small as updating your resume.

Enflonsia, Merck’s medication to treat respiratory syncytial virus (RSV) in infants, has been approved by the FDA. It will now compete with Sanofi and AstraZeneca’s Beyfortus, which was approved by the FDA in July 2023.

No matter your industry, thousands of American workers have been affected by widespread layoffs in 2025.

Stefan Falk, a leadership consultant who studies workplace psychology, has spent more than 30 years helping thousands of individuals and CEOs at multimillion-dollar organizations.

An interesting look at how women can take control of their careers and beat the broken rung - Click here

Life Science Washington has reported that from 2013 to 2023, there has been a 50% job growth. This life sciences cluster has outpaced both national life science growth and private sector growth in Washington.

Sabina Nawas, a former Microsoft HR executive, so many people ‘simply don’t get the basics right.’ Nawas spent 15 years at Microsoft before leaving to start an executive coaching company where she works with senior leaders.

After a patient became ill with a potential drug-induced liver injury, Pfizer announced it would discontinue the development of danuglipron, an orally administered experimental treatment for weight management.

As the workforce rapidly evolves, here is an interesting look at Workforce Trends put together by TI Verbatim Consulting…

People can go to extremes to be taken seriously and earn respect from their peers. Sometimes in doing so they do not sound very smart at all.

LinkedIn has recently posted a Skills on the Rise report showcasing the fastest-growing skills in the US. These skills can help you differentiate yourself among candidates.